Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm) offers postgraduate programme by research in Healthcare Biotechnology. Healthcare Biotechnology serves as pivotal role in the realization of the Malaysian National Biotechnology Policy. IPharm aims to develop new pharmaceuticals and nutraceuticals with commercialisation potential by:
Identifying niche areas in pharmaceutical and nutraceutical biotechnology by exploiting readily available natural resources in Malaysia.
Ensuring regulatory compliance in pharmaceutical and nutraceutical biotechnology R&D.
Sustaining prioritized R&D activities and adapt to the latest technology in drug discovery and development research area.
Research Thrust Areas
Healthcare Biotechnology
Health Biotechnology
Molecular Medicine
Rapid Diagnostics
Vaccinology
Tissue Engineering
Biomaterial Science
Pharmacogenetics
Novel Therapy
Mechanisms of Disease
Cancer Research
RNA Technology
To be confirmed
Universiti Sains Malaysia (USM)
Main Campus,
MINDEN,
Penang,
11800, Malaysia
Applicants should possess the following:
A Bachelor's degree in Pharmacy, Pharmaceutical Sciences, Chemistry (Pure or Applied), Microbiology, Biotechnology, or related area with:
A minimum CGPA of 3.00/4 or equivalent for International students
A minimum score of 35 in Internet-based TOEFL (Test of English as a Foreign Language); or
A minimum of Band 5 in IELTS (International English Language Testing System); or
A minimum score of 154 in Cambridge English Advance (CAE); or
A minimum score of 154 in Cambridge Proficiency Advance (CPE); or
A minimum score of 36 in Pearson Test of English (PTE); or
A minimum of Band 2 in MUET (Malaysian University English Test)
